Navigation Links
Little known pregnancy disease, Hyperemesis Gravidarum, receives awareness with a $20,000 donation from the H.E.R. Foundation to begin Genome Research at UCLA
Date:7/9/2012

LEESBURG, Va., July 9, 2012 /PRNewswire-iReach/ -- The HER Foundation (Hyperemesis Education & Research), the voice of HG, presented $20,000 to UCLA's medical research department and the Hyperemesis Gravidarum Genome Project. Hyperemesis Gravidarum (HG) is a debilitating and potentially life-threatening pregnancy disease marked by rapid weight loss, malnutrition, and dehydration due to unrelenting nausea and/or vomiting with potential adverse consequences for the newborn(s). HG is the second leading cause of hospitalization during pregnancy, yet few dollars are granted for research.

The research, conducted by lead researcher Dr. Marlena Fejzo, will focus on identifying the gene associated with Hyperemesis Gravidarum (HG), and how the effects of this disease, brought on by pregnancy, affect the mother and child.  Dr. Fejzo states, "The latest award of $20,000 from the HER Foundation will enable us to use an exciting novel technology to identify the gene(s) and corresponding biological pathways related to HG in HG-families." 

Kimber MacGibbon, co-founder of the HER Foundation says, "We are very excited to support this important genetic study that will give us greater understanding of Hyperemesis Gravidarum, as well as the opportunity to identify mothers at risk for HG so they can receive proactive care. Ultimately, this study will improve the care of those with HG and disprove the erroneous beliefs about the cause of HG."

The national cost of treating HG in the inpatient setting increased 50% from $167 million in 2000 to $250 million in 2009. Recent studies show HG is associated with low birth weight, intrauterine growth restriction, preterm delivery, and fetal and neonatal death.  Elective pregnancy termination in a large cohort of women with Hyperemesis Gravidarum have also been shown in recent studies. Recurren
'/>"/>

SOURCE The HER Foundation
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Medzilla.com Special Report: Unemployed Can Breathe a Little Freer After Supreme Court's Affordable Care Act Ruling
2. Study dusts sugar coating off little-known regulation in cells
3. Eczema in Babies Due to Stress in Pregnancy
4. Morning Sickness or NVP: National Survey of Nurse Practitioners Points to Underreporting of Common Condition in Pregnancy
5. Upsher-Smith Launches B-Nexa® Prescription Prenatal Vitamin With B Vitamins and Ginger for Nausea and Vomiting of Pregnancy
6. Lupin Receives FDA Approval for Generic LYRICA(R)
7. Bacterin Receives Letter From NYSE MKT LLC Regarding Timely Notice of Record Date for 2012 Annual Meeting of Stockholders
8. Synedgen’s Synoplex® Receives FDA Indexing for Use in the Treatment of Chronic Wounds in Pachyderms
9. Nourish the World! Terra Biotech Receives Thanks and Praise After First Shipment of 10,000 Servings of Nectr Core Vitamin Powder to Orphans in Ghana, Africa
10. PharmaDirections Succeeds Through its Client’s Successes: Cortendo Receives Positive Orphan Drug Opinion from EMA for NormoCort for Cushing’s Disease
11. Exotic Automation & Supply Receives Ford’s 2011 World Excellence Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... 2013 Vestiage, Inc. (stock symbol ... on science-based research and development, sales and marketing ... nutraceuticals, announced today that it is awarding exclusive ... sale of Reluma Skin Illuminating Facial Care. Qualified ... by sending an email to info(at)vestiageinc(dot)com and putting ...
(Date:5/23/2013)... , May 23, 2013 Venaxis, Inc. (Nasdaq: ... focused on obtaining FDA clearance and commercializing its rapid, ... the pricing of an underwritten public offering of 10,000,000 ... purchase 3,500,000 shares of its common stock at an ... public offering price of $1.25 per share and related ...
(Date:5/23/2013)... May 23, 2013 Patheon Inc ... services to the global pharmaceutical industry, will host a ... Approaches to Testing” on Tuesday, June 4, 2013 at ... manufacturers are required to comply with regulations for cleaning ... with limited scientific underpinning and little evaluation of risk. ...
(Date:5/23/2013)... MA (PRWEB) May 23, 2013 ... inch wide and provide 15 mm travel range ... The small dimensions make these new positioners ... confined spaces. A vacuum rated version is also ... Drawings, specifications and datasheets can be found at: ...
Breaking Biology Technology:Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 2Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 3Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 4Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 5Venaxis Announces Pricing of Offering of Common Stock and Warrants 2Venaxis Announces Pricing of Offering of Common Stock and Warrants 3Patheon to Present on “Cleaning Validation: Science, Risk and Novel Approaches to Testing” 2Precision Positioning System Uses Miniaturezed Piezo Linear Motor: LPS-24 Linear Stage by PI 2
... 1 PSKW, LLC, a New Jersey-based,leading provider ... today that it has significantly expanded the scope ... the Supreme Court of the State,of New York, ... Inc.,("McKesson"), a wholly-owned subsidiary of McKesson Corporation. PSKW ...
... China, Sept. 1 /Xinhua-PRNewswire-FirstCall/ -- China,Pharma Holdings, ... which,develops, manufactures, and markets generic and branded ... the Susquehanna Financial,Group, LLP (SIG)"Beijing Management Summit" ... the 12th of September 2008., Attending ...
... , With some 20,000 UK children with ... year, new guidance from the National Institute for ... the way children,manage their diabetes, granting more freedom ... insulin pump therapy. The new,recommendations finally acknowledge key ...
Cached Biology Technology:PSKW Expands Its Lawsuit Against McKesson to Seek Assignment of McKesson's Patent Application 2British School Kids With Diabetes Gain First Time Freedom From Injections With New Insulin Pump Guidelines 2British School Kids With Diabetes Gain First Time Freedom From Injections With New Insulin Pump Guidelines 3British School Kids With Diabetes Gain First Time Freedom From Injections With New Insulin Pump Guidelines 4
(Date:5/23/2013)... treating cerebral palsy with autologous cord blood. Following a ... old boy had been in a persistent vegetative state ... after treatment with the cord blood containing stem cells, ... child learned to speak simple sentences and to move. ... dispel the long-held doubts about the effectiveness of the ...
(Date:5/23/2013)... world,s largest and fastest growing open-access publishers, announces ... in Bioengineering and Biotechnology . , A ... in Bioengineering and Biotechnology will provide a ... and biotechnology research to be disseminated and discussed. ... will provide an open-science and interactive web ...
(Date:5/23/2013)... age when microbial pathogens are growing increasingly resistant to ... team of Wisconsin scientists has synthesized a potent new ... cause staph infections. , Writing online in the ... led by University of Wisconsin-Madison chemistry Professor Helen Blackwell ... behavior of Staphylococcus aureus , a bacterium at ...
Breaking Biology News(10 mins):First successful treatment of pediatric cerebral palsy with autologous cord blood 2Frontiers launches new open-access journal in Bioengineering and Biotechnology 2University of Wisconsin chemists find new compounds to curb staph infection 2
... YORK Computed Tomography (CT) scans are an increasingly used ... organ or tissue. The value of CT scanning to diagnose ... these scans being used too frequently, in some cases unnecessarily" ... scans over the course of a persons life" In ...
... Sirtris Pharmaceuticals, Inc. (NASDAQ: SIRT), a biopharmaceutical company focused ... diseases of aging, announced today that findings in the ... candidates that offer a promising, new approach to treating ... SIRT1, a gene that controls the aging process. ...
... of nanotechnologys potential risks growing" If so, ... newspapers and newswiresenvironmental and consumer organizations, scientists, law ... broadcast journalists decide to cover a nanotechnology story, ... and television correspondents face special challenges reporting on ...
Cached Biology News:Columbia researchers: Growth of CT scan use may lead to significant public health problem 2Columbia researchers: Growth of CT scan use may lead to significant public health problem 3Sirtris unveils promising, novel SIRT1 activators for treating diseases of aging 2Sirtris unveils promising, novel SIRT1 activators for treating diseases of aging 3Nanotechnology and the media: The inside story 2
... K-12 strain ideally suited as an initial ... efficiency, blue/white screening capability (with appropriate plasmids) ... high yields of excellent quality plasmid DNA. ... useful as a stringent host due to ...
... kit contains all the reagents required for ... c reductase activity in cell and tissue ... (ER)]. It has been tested on samples ... kidney, brain, spleen, and heart muscle from ...
... an automated, confocal, real-time, single cell kinetic ... integrated into a single, compact unit. ... high-resolution, automated confocal imaging with sophisticated imaging ... assays. The system allows the user to ...
... Invitrogen makes blotting of E-PAGE Gels easier ... fiber blotting pad and several types of ... fit 8.6 cm x 13.5 cm E-PAGE ... membranes are designed for western transfer of ...
Biology Products: